GenomeBC has established a leading role in scientific research in the country and has focused attention in the last year on learning about the pandemic to advance treatment techniques and to prepare us for future health threats. Pascal Spothelfer, the president president and CEO of GenomeBC, talks to BIV publisher and editor-in-chief Kirk LaPointe about the non-profit organization’s contributions to the genomic understanding of COVID-19.